"lung cancer" trang 5 - tải miễn phí từ tailieunhanh
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
9    35    1
Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia

Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
10    38    1
LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1

LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1
6    22    1
LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer

LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer
8    40    1
Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer

Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer
9    56    1
Pre-existing interstitial lung disease is associated with onset of nivolumabinduced pneumonitis in patients with solid tumors: A retrospective analysis

Pre-existing interstitial lung disease is associated with onset of nivolumabinduced pneumonitis in patients with solid tumors: A retrospective analysis
8    25    1
MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-smallcell lung cancer

MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-smallcell lung cancer
16    44    1
Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients

Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients
10    62    3
Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings

Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
11    13    1
Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer

Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer
23    11    1
Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer

Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
10    15    1
Prevalence of subclinical lung cancer detected at autopsy: A systematic review

Prevalence of subclinical lung cancer detected at autopsy: A systematic review
11    1    1
MALAT1-regulated gene expression profiling in lung cancer cell lines

MALAT1-regulated gene expression profiling in lung cancer cell lines
14    1    1
Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study

Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study
15    1    1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1
HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non‑small cell lung cancer

HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non‑small cell lung cancer
9    2    1
Trends and predictions of lung cancer incidence in Jiangsu Province, China, 2009– 2030: A bayesian age-period-cohort modelling study

Trends and predictions of lung cancer incidence in Jiangsu Province, China, 2009– 2030: A bayesian age-period-cohort modelling study
9    1    1
Trends in hospitalization and in‑hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020

Trends in hospitalization and in‑hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020
12    2    1
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes
9    1    1
Long-term results of postoperative unsuspected small cell lung cancer on real-world data

Long-term results of postoperative unsuspected small cell lung cancer on real-world data
10    2    1